Sentinel node biopsy for clear cell sarcoma

European Journal of Surgical Oncology

Volumn 32, Issue 9, 2006, Pages 996-999

  van Akkooi, A C J ^a   Verhoef, C ^a   van Geel, A N ^a   Kliffen, M ^a   Eggermont, A M M ^a   de Wilt, J H W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Clear cell sarcoma; Clear cell sarcoma of tendons and aponeuroses; Malignant melanoma of soft tissue; Sentinel node

Indexed keywords

EOSIN; HEMATOXYLIN; NANOCOLL; NANOCOLL TC 99M;

ACCURACY; ADRENAL METASTASIS; ADULT; ARTICLE; AXILLARY LYMPH NODE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL SARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXPERIENCE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN SURGERY; SKIN TRANSPLANTATION; SOFT TISSUE SARCOMA; TREATMENT REFUSAL;

ADULT; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SARCOMA, CLEAR CELL; SENTINEL LYMPH NODE BIOPSY; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TREATMENT OUTCOME;

EID: 33750375533     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.03.044     Document Type: Article

References (30)

1. Enzinger F.M. Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer 18 (1965) 1163-1174
2. Mukai M., Torikata C., Iri H., et al. Histogenesis of clear cell sarcoma of tendons and aponeuroses. An electron-microscopic, biochemical, enzyme histochemical, and immunohistochemical study. Am J Pathol 114 2 (1984) 264-272
3. Jacobs I.A., Chang C.K., Guzman G., and Salti G.I. Clear cell sarcoma: an institutional review. Am Surg 70 4 (2004) 300-303
4. Chung E.B., and Enzinger F.M. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 7 5 (1983) 405-413
5. Boudreaux D., and Waisman J. Clear cell sarcoma with melanogenesis. Cancer 41 4 (1978) 1387-1394
6. John Antoniades M.D. Uncommon malignant tumors (1982), MASSON Publishing USA, Inc., Philadelphia
7. Kuiper D.R., Hoekstra H.J., Veth R.P., and Wobbes T. The management of clear cell sarcoma. Eur J Surg Oncol 29 7 (2003) 568-570
8. Lucas D.R., Nascimento A.G., and Sim F.H. Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases. Am J Surg Pathol 16 12 (1992) 1197-1204
9. Eckardt J.J., Pritchard D.J., and Soule E.H. Clear cell sarcoma. A clinicopathologic study of 27 cases. Cancer 52 8 (1983) 1482-1488
10. Deenik W., Mooi W.J., Rutgers E.J., Peterse J.L., Hart A.A., and Kroon B.B. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases. Cancer 86 6 (1999) 969-975
11. Finley J.W., Hanypsiak B., McGrath B., Kraybill W., and Gibbs J.F. Clear cell sarcoma: the Roswell Park experience. J Surg Oncol 77 1 (2001) 16-20
12. Al-Refaie W.B., Ali M.W., Chu D.Z., Paz I.B., and Blair S.L. Clear cell sarcoma in the era of sentinel lymph node mapping. J Surg Oncol 87 3 (2004) 126-129
13. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 4 (1992) 392-399
14. Morton D.L., Wen D.R., Foshag L.J., Essner R., and Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 11 9 (1993) 1751-1756
15. Balch C.M., Soong S., Ross M.I., Urist M.M., Karakousis C.P., Temple W.J., et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7 2 (2000) 87-97
16. Eggermont A.M. European approach to the treatment of malignant melanoma. Curr Opin Oncol 14 2 (2002) 205-211
17. Flugstad D.L., Wilke C.P., McNutt M.A., Welk R.A., Hart M.J., and McQuinn W.C. Importance of surgical resection in the successful management of soft tissue sarcoma. Arch Surg 134 8 (1999) 856-861 [discussion 861-2]
18. Lewis J.J., Leung D., Espat J., Woodruff J.M., and Brennan M.F. Effect of reresection in extremity soft tissue sarcoma. Ann Surg 231 5 (2000) 655-663
19. Statius Muller M.G., Borgstein P.J., Pijpers R., van Leeuwen P.A., van Diest P.J., Gupta A., et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 7 6 (2000) 461-468
20. Uren R.F., Thompson J.F., and Howman-Giles R. Sentinel lymph node biopsy in patients with melanoma and breast cancer. Intern Med J 31 9 (2001) 547-553
21. Alex J.C., Weaver D.L., Fairbank J.T., Rankin B.S., and Krag D.N. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 2 5 (1993) 303-308
22. Albertini J.J., Cruse C.W., Rapaport D., et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223 2 (1996) 217-224
23. Cook M.G., Green M.A., Anderson B., et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 200 3 (2003) 314-319
24. van Akkooi A.C., de Wilt J.H., Verhoef C., et al. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 42 3 (2006) 372-380
25. Riad S., Griffin A.M., Liberman B., et al. Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 426 (2004) 129-134
26. Estourgie S.H., Nieweg O.E., Valdes Olmos R.A., Hoefnagel C.A., and Kroon B.B. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 10 6 (2003) 681-688
27. Statius Muller M.G., van Leeuwen P.A., de Lange-De Klerk E.S., et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer 91 12 (2001) 2401-2408
28. Jansen L., Nieweg O.E., Peterse J.L., Hoefnagel C.A., Olmos R.A., and Kroon B.B. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 87 4 (2000) 484-489
29. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17 3 (1999) 976-983
30. Picciotto F., Zaccagna A., Derosa G., et al. Clear cell sarcoma (malignant melanoma of soft parts) and sentinel lymph node biopsy. Eur J Dermatol 15 1 (2005) 46-48